| 中文名: | 巴非替尼;(S)-N-(3-([4,5'-联嘧啶]-2-基氨基)-4-甲苯基)-4-((3-(二甲氨基)吡咯烷-1-基)甲基)-3-(三氟甲基)苯甲酰胺 |
| 中文别名: | 巴氟替尼;4-[[(3S)-3-二甲基氨基吡咯烷-1-基]甲基]-N-[4-甲基-3-[(4-嘧啶-5-基嘧啶-2-基)氨基]苯基]-3-(三氟甲基)苯甲酰胺;N-[3-([4,5‘-联嘧啶]-2-基氨基)-4-甲基苯基]-4-[[(3S)-3-(二甲基氨基)-1-吡咯烷基]甲基]-3-(三氟甲基)苯甲酰胺 |
| 英文名称: | Bafetinib |
| 英文别名: | N-[3-([4,5?-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide; INNO 406; NS 187; |
| CAS No.: | 859212-16-1 |
| 分子式: | C30H31F3N8O |
| 分子量: | 576.62 |
| 性状: | Melting Point: NA |
| 储存: | NA |
| 安全术语: | |
| 风险术语: | |
| 危险品标志: | |
| 危险品运输编号: | |
| 用途: | Aplications: A substituted benzamide derivative structurally related to STI-571 (Imatinib Mesylate). It was identified as highly potent Bcr-Abl kinase inhibitor. |




VIP会员![2-(2-(2-(2-(4-(苯并[d]噻唑-2-基)苯氧基)乙氧基)乙氧基)乙氧基)乙醇 2-(2-(2-(2-(4-(苯并[d]噻唑-2-基)苯氧基)乙氧基)乙氧基)乙氧基)乙醇](https://yunshiji.oss-cn-shenzhen.aliyuncs.com/cas/2274723-90-7.png)
![3-碘-2,4,5,6-四氢-1H-环丁烷并[f]茚 3-碘-2,4,5,6-四氢-1H-环丁烷并[f]茚](https://yunshiji.oss-cn-shenzhen.aliyuncs.com/cas/2271393-82-7.png)




















粤公网安备44196802000105号